Clinical Trial Update: Study of In-line Pressure Using Various Techniques of Subcutaneous Administration of Fluids Enabled by Human Recombinant Hyaluronidase (INFUSE-AT1A) [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating subcutaneous fluid administration enabled by recombinant human hyaluronidase (INFUSE-AT1A) in dehydration. The study was termina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dehydration

Drugs mentioned

• INFUSE-AT1A (recombinant human hyaluronidase)

Snippet

Sponsor: Baxter Healthcare Corporation | Conditions: Dehydration | Phase 4 | Status: TERMINATED | Results posted: 2011-10-18